Jing Xu - Profile and Investment Details

Investor Profile

Jing Xu is a Venture Capital, Private Equity Firm based in Singapore, Central Singapore Community Development Council, Singapore with a diverse investment portfolio that includes companies such as Zhangkong Tangniaobing, Aohua, Starna Therapeutics, Medilink Therapeutics, ImmuneOnco Biopharma, Cytek Biosciences, Baixing Pingan Yaofang, ABclonal, Ansun BioPharma, Sciwind Biosciences, HiFiBiO, ChemLex, Nucleix, Laviana Pharma, Edge Medical Robotics, Cleveland Diagnostics, Zhenge Biotech, Just Medical, CANbridge Pharmaceuticals, Burning Rock Biotech, WuXi AppTec, WinnTi Medical, . Over time, Jing Xu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jing Xu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Life Science, Information Technology (IT), Manufacturing, Biotechnology, Drug Development, Genomics, Clinical Trials, Research, Metabolic Health, Health Diagnostics, Medical, B2B, Media and Entertainment, Personal Health, Pharmaceuticals, Biometrics may find it worthwhile to explore potential connections with Jing Xu, as their portfolio suggests a familiarity and interest in this area.

Understanding Jing Xu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.